Published in Johns Hopkins Med J on October 01, 1972
DTP immunization status and tetanus antitoxin titers of Mexican American children ages six months through eleven years. Am J Public Health (1988) 0.89
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science (2000) 7.41
Subtyping isolates of Haemophilus influenzae type b by outer-membrane protein profiles. J Infect Dis (1981) 6.34
Genetic relationships of serologically nontypable and serotype b strains of Haemophilus influenzae. Infect Immun (1986) 5.92
A population genetic framework for the study of invasive diseases caused by serotype b strains of Haemophilus influenzae. Proc Natl Acad Sci U S A (1985) 4.48
Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev Infect Dis (1990) 4.06
Outer membrane protein and biotype analysis of pathogenic nontypable Haemophilus influenzae. Infect Immun (1982) 3.78
Purification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates. J Clin Invest (1983) 3.33
Purification and partial characterization of outer membrane proteins P5 and P6 from Haemophilus influenzae type b. Infect Immun (1985) 2.99
The Health Belief Model and prediction of dietary compliance: a field experiment. J Health Soc Behav (1977) 2.73
Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet (1991) 2.63
Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease. N Engl J Med (1968) 2.61
A field experiment to evaluate various outcomes of continuity of physician care. Am J Public Health (1974) 2.56
Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial. JAMA (1998) 2.50
Experimental Haemophilus influenzae type b meningitis: immunological investigation of the infant rat model. Infect Immun (1978) 2.46
Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group. JAMA (1992) 2.40
Prospects for prevention of Haemophilus influenzae type b disease by immunization. J Infect Dis (1986) 2.31
Comparison of outer-membrane protein subtypes and biotypes of isolates of Haemophilus influenzae type b. J Infect Dis (1981) 2.07
Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. JAMA (1993) 2.05
Outer-membrane protein subtypes of Haemophilus influenzae type b and spread of disease in day-care centers. J Infect Dis (1981) 2.03
A new approach to explaining sick-role behavior in low-income populations. Am J Public Health (1974) 1.88
Human antibody responses to lipopolysaccharide after meningitis due to Haemophilus influenzae type b. J Infect Dis (1982) 1.87
Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis (1997) 1.86
Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia. Infect Immun (1983) 1.78
Differences in surface expression of NspA among Neisseria meningitidis group B strains. Infect Immun (1999) 1.76
Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr (1993) 1.69
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
Compliance with a medical regimen for asthma: a test of the health belief model. Public Health Rep (1978) 1.61
Studies on the effect of experimental nonketotic diabetes mellitus on antibacterial defense. I. Demonstration of a defect in phagocytosis. J Exp Med (1966) 1.60
Predicting mothers' compliance with pediatric medical regimens. J Pediatr (1972) 1.59
Importance of complement source in measuring meningococcal bactericidal titers. Clin Diagn Lab Immunol (2001) 1.57
Spread of Haemophilus influenzae type b: recent epidemiologic and therapeutic considerations. J Pediatr (1980) 1.55
Second episodes of Haemophilus influenzae type b disease following rifampin prophylaxis of the index patients. Pediatr Infect Dis J (1987) 1.47
Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa. J Infect Dis (2009) 1.47
Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates. J Immunol (1995) 1.47
Antibody responses to Haemophilus influenzae type b polysaccharide vaccine in relation to Km(1) and G2m(23) immunoglobulin allotypes. J Infect Dis (1986) 1.43
Variability in the functional activity of vaccine-induced antibody to Haemophilus influenzae type b. Pediatr Res (1990) 1.43
Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein. Lancet (1986) 1.42
Complement-mediated bactericidal activity of human antibodies to poly alpha 2-->8 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B. J Infect Dis (1995) 1.41
Immunogenicity of Haemophilus influenzae type b polysaccharide--diphtheria toxoid conjugate vaccine in adults. J Pediatr (1984) 1.41
Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide. J Immunol (1987) 1.38
Haemophilus influenzae type B disease in a day care center: eradication of carrier state by rifampin. Pediatrics (1979) 1.37
Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine. N Engl J Med (1986) 1.36
Do children with recurrent Haemophilus influenzae otitis media become infected with a new organism or reacquire the original strain? J Pediatr (1984) 1.36
Motivations as predictors of health behavior. Health Serv Rep (1972) 1.36
Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b. J Infect Dis (1990) 1.35
Comparison of outer membrane protein subtypes of Haemophilus influenzae type b isolates from healthy children in the general population and from diseased patients. J Clin Microbiol (1983) 1.34
Increased susceptibility of splenectomized rats to infection with Diplococcus pneumoniae. J Infect Dis (1972) 1.32
Continuity of pediatrician: new support for an old shibboleth. J Pediatr (1974) 1.31
Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease. J Pediatr (1988) 1.30
Scales for measuring health belief model dimensions: a test of predictive value, internal consistency, and relationships among beliefs. Health Educ Monogr (1977) 1.30
Expression of human aldose and aldehyde reductases. Site-directed mutagenesis of a critical lysine 262. J Biol Chem (1991) 1.29
Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(1) immunoglobulin allotype. J Clin Invest (1984) 1.28
Haemophilus influenzae infections in Fresno County, California: a prospective study of the effects of age, race, and contact with a case on incidence of disease. J Infect Dis (1980) 1.26
Infectious diseases and child day care. Pediatrics (1984) 1.25
An idiotypic marker associated with a germ-line encoded kappa light chain variable region that predominates the vaccine-induced human antibody response to the Haemophilus influenzae b polysaccharide. J Clin Invest (1991) 1.24
Antibody-dependent alternative pathway killing of Haemophilus influenzae type b. Infect Immun (1984) 1.24
Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B. Infect Immun (2001) 1.21
Outer membrane protein subtypes and biotypes of Haemophilus influenzae type b: relation between strains isolated in 1934-1954 and 1977-1980. J Infect Dis (1983) 1.20
Comparison of rifampin and ampicillin in day care center contacts of Haemophilus influenzae type b disease. Pediatrics (1980) 1.17
Rifampin prophylaxis for contacts of Haemophilus influenzae type b disease. JAMA (1981) 1.14
Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B. Clin Vaccine Immunol (2008) 1.13
A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides. Immunol Invest (2001) 1.13
Antimicrobial susceptibility patterns of Haemophilus isolates from children in eleven developing nations. BOSTID Haemophilus Susceptibility Study Group. Bull World Health Organ (1990) 1.12
Infectious arthritis in the neonate caused by Haemophilus influenzae. Am J Dis Child (1975) 1.12
Oligoclonality of serum immunoglobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14, and 23F. Infect Immun (1997) 1.12
Countercurrent immunoelectrophoresis in the diagnosis of Haemophilus influenzae type b infection: relationship of detection of capsular antigen to age, antibody response, and therapy. Am J Dis Child (1977) 1.11
A major crossreactive idiotype associated with human antibodies to the Haemophilus influenzae b polysaccharide. Expression in relation to age and immunoglobulin G subclass. J Clin Invest (1990) 1.11
Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants. Pediatrics (1987) 1.11
Imperfect memory and the development of Haemophilus influenzae type B disease. Pediatr Infect Dis J (2001) 1.10
Serum opsonic activity after immunization of adults with Haemophilus influenzae type b-diphtheria toxoid conjugate vaccine. Infect Immun (1985) 1.09
Effect of rifampin chemoprophylaxis on carriage eradication and new acquisition of Haemophilus influenzae type b in contacts. Pediatrics (1985) 1.09
Lipopolysaccharide gel profiles of Haemophilus influenzae type b are not stable epidemiologic markers. J Clin Microbiol (1986) 1.07
Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide. J Immunol (1993) 1.07
Circulating capsular antigen in infant rats infected with Haemophilus influenzae type b. J Infect Dis (1977) 1.07
Concentrations of antibodies in paired maternal and infant sera: relationship to IgG subclass. J Pediatr (1987) 1.04
Epidemiology and prospects for prevention of disease due to Haemophilus influenzae in developing countries. Rev Infect Dis (1989) 1.03
Interactive effect of genes associated with immunoglobulin allotypes and HLA specificities on susceptibility to Haemophilus influenzae disease. J Immunogenet (1985) 1.02
Relation of age, race, and allotype to immunoglobulin subclass concentrations. Pediatr Res (1985) 1.02
Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease. FEMS Immunol Med Microbiol (1999) 1.01
Haemophilus influenzae type b polysaccharide vaccines. J Pediatr (1985) 1.00
Cellulitis due to Haemophilus influenzae type B. Antigenemia and antibody responses. Am J Dis Child (1976) 1.00
A mutation in Bruton's tyrosine kinase as a cause of selective anti-polysaccharide antibody deficiency. J Pediatr (2001) 1.00
The biology of Haemophilus influenzae type b vaccination failure. J Infect Dis (1992) 1.00
Increased voluntary running and decreased motor coordination in mice after neonatal corticosterone implantation. Exp Neurol (1968) 0.99
Development of Haemophilus influenzae type b meningitis in a household contact treated with rifampin. Pediatrics (1982) 0.99
Mothers' health beliefs and children's clinic visits: a prospective study. J Community Health (1977) 0.99
Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. J Pediatr (1987) 0.98
Prospective surveillance of Haemophilus influenzae type b disease in Dallas County, Texas, and in Minnesota. Pediatrics (1987) 0.97
Modulation of the immune system by human milk and infant formula containing nucleotides. Pediatrics (1998) 0.97
Human immunoglobulin M paraproteins cross-reactive with Neisseria meningitidis group B polysaccharide and fetal brain. Infect Immun (1995) 0.97
Functional activity of different IgG subclass antibodies against type b capsular polysaccharide of Haemophilus influenzae. J Immunol (1986) 0.96
Nosocomial spread of Haemophilus influenzae type b infection documented by outer membrane protein subtype analysis. J Pediatr (1983) 0.96
Subnormal serum concentrations of IgG2 in children with frequent infections associated with varied patterns of immunologic dysfunction. J Pediatr (1990) 0.94
Outer membrane protein subtypes and investigation of recurrent Haemophilus influenzae type b disease. J Pediatr (1982) 0.91
Physician productivity and medical care. J Pediatr (1970) 0.91
Factors influencing mothers' compliance with a medication regimen for asthmatic children. J Asthma Res (1978) 0.90
Siblings of patients with Haemophilus meningitis have impaired anticapsular antibody responses to Haemophilus vaccine. J Pediatr (1983) 0.89
Lack of efficacy of Haemophilus b polysaccharide vaccine in Minnesota. JAMA (1988) 0.89
Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine? JAMA (2000) 0.89
Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1. Infect Immun (1994) 0.88